Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Filings indexed 861 across all filing types
Latest filing 2024-05-21 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period en…
Regulatory Filings
2024-05-21 English
Board Meeting — Financial Results/Fund Raising
Regulatory Filings
2024-05-21 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a notification from Wockhardt Limited to stock exchanges about a credit rating assigned by ICRA Limited. It details the credit ratings for various debt instruments and mentions the company's liquidity and fund raising. The document is an update on financing and credit status, not a full financial report or earnings release. It does not contain financial statements or detailed analysis but is an announcement related to the company's capital and financing activities. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification, so CAP is appropriate.
2024-05-16 English
Statement of deviation(s) or variation(s) under Reg. 32
Capital/Financing Update Classification · 95% confidence The document is a statement on deviation or variation of funds raised through a Qualified Institutions Placement (QIP) for the quarter ended 31st March 2024. It confirms no deviation in the utilization of issue proceeds and includes a detailed annexure with fund utilization data. The document references compliance with SEBI regulations and is addressed to stock exchanges. It is not a full financial report but an update related to capital raising and fund usage. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 4035 characters, which is sufficient to contain substantive information rather than just an announcement. Hence, the classification is CAP with high confidence.
2024-05-15 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended 31st March, 2024' and is issued pursuant to SEBI regulations related to the utilization of proceeds from a Qualified Institutional Placement (QIP). It includes detailed information on the use of funds, certifications, and comments from the monitoring agency and the company's board. The report is comprehensive, covering financial utilization and compliance with the issue objectives. It is not an announcement of a report publication but the actual monitoring report itself. This type of document is related to capital raising and monitoring the use of proceeds, which fits the category of Capital/Financing Update (CAP).
2024-05-15 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a notification from Wockhardt Limited to stock exchanges about a credit rating assigned by ICRA Limited. It details the assigned long-term and short-term credit ratings and the factors considered in the rating. The document is short (1686 characters) and serves as an announcement of a credit rating update, which relates to the company's financing and creditworthiness. It does not contain financial statements, detailed financial analysis, or full report content. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as credit rating announcements.
2024-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.